Sitagliptin Insulin Evaluated in Hospitalized T2D Patients (CME/CE)
(MedPage Today) -- Combination proved non-inferior to standard basal-bolus insulin treatment
Source: MedPage Today State Required CME - Category: Consumer Health News Source Type: news